An unexpected "storm"
Release time:
2020-07-22
An unexpected "storm"
2018 10# July 18 Early in the morning, I received a phone call from manager Zhou of the quality department of a major customer company, saying that the HYA53 cable produced by our company was sent to a well-known testing organization in Shanghai for testing, and many indicators of the product failed. Hearing the news, I was like a thunderbolt. For so many years, there has never been a third-party failure test for local telephone cables. Is the quality of our products really so poor this time? If it is true, then where is the reputation of our company, where is the integrity, and will customers still exist?
After the tension, I immediately asked what indicator was unqualified. The customer then sent me the unqualified items. I quickly looked at them and found that among the nearly 20 indicators, there were four unqualified indicators: resistance, capacitance, attenuation and near string. I immediately went to check the production and inspection records, and also asked the employees in charge of production and inspection. The records showed that the product indexes were qualified and the indexes were relatively large, and there was no abnormal situation in the production process. Resistance, capacitance and attenuation are all related to length. I immediately realized that this sample may be a problem with the test length.
So I asked the relevant personnel if there was any length deviation. The operator reflected that because he knew that this cable was a sample for testing, more than 2 meters were reserved at the inner and outer ends for testing the length of the wiring, and the length was written as 100 meters according to the customer's requirements. Therefore, the actual length of the cable should be about 105 meters. I immediately contacted the personnel of the testing organization and asked her to help check whether there was any length deviation. The next day I got a reply, the actual length is 105-107 meters, and the testing organization tests according to 100 meters on the certificate. The
detection mechanism said that the resistance and capacitance indexes were qualified after conversion by length, but the attenuation and near string indexes were still unqualified after conversion by length. I wondered, not knowing how to explain, and asked for the cable to be retested, but was refused. So I asked the testing agency to send me the original data of the test. The testing agency did not agree with my request. They said that there was no practice of retesting unqualified products, and there was no precedent for sending the original data to customers.
The testing agency does not agree to retest. There are only two options before us: one is to re-produce a cable to test and help the customer get a qualified test report; The second is to analyze the test data of the product to see if the test is wrong. If there is a mistake, we can appeal. For our customers, there is no doubt that the first choice is the best. We can get the test report as soon as possible and have an explanation. It is undoubtedly very difficult for the testing organization to provide the original data. However, our general manager Li didn't think so after knowing the situation. He said that if we send the products for inspection again, the inspection fee of more than 10,000 yuan is a trivial matter. The key is that customers will think that we are not qualified even in the sample line, so the products we supply them must be junk products at ordinary times. We will be regarded as dishonest suppliers, and problems may occur in future cooperation, losing our most important customer right now. Therefore, we must confirm whether our products are really problematic. It is a very important step for testing agencies to provide data. If handled well, it may turn bad things into good things.
was deadlocked for nearly two weeks. The customer was eager to use the test report and asked us to get the qualified report as soon as possible, and some doubts were revealed in the words. The production department rearranged the production of a sample line. The sales department contacted the major customers in Jiangsu and borrowed their authoritative US DCM equipment for testing. The comprehensive management department arranged a special car and I personally sent the products to Jiangsu for testing. One day a back and forth, in exchange for satisfactory full performance qualified test results, which makes us more confident in our products. Using this convincing data, and under the strong request of our customers, the testing organization finally sent us the original data. After getting the data, the relevant personnel of the company held a special meeting to analyze and study the data, and found that the testing organization applied the standard incorrectly and caused the wrong judgment. We wrote the relevant misunderstanding and sent it to the testing agency, and they finally approved our complaint and re-judged the product as qualified. After
, manager Zhou told me in wechat: "you are right. I believe in the quality of your products, because your leaders attach great importance to the quality of products, and your professional level is higher than that of the testing institutions!" I sent her a happy smile. An unexpected storm finally cleared the weather and turned a bad thing into a good thing. At this time, I found the sun is so warm and bright ...... (Lu Chaofang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page